Evaluation of a pharmacist-led antimicrobial stewardship service in a pediatric emergency department

K M MacMillan1,2, M MacInnis1,2, E Fitzpatrick1,2

  • 1Dalhousie University, Halifax, Canada.

Insights

A pharmacist-led antimicrobial stewardship service in a pediatric emergency department did not significantly reduce return visits. However, it improved antimicrobial use and expedited notification times for discharged patients.

Area of Science:

  • Pediatric Emergency Medicine
  • Antimicrobial Stewardship
  • Pharmacist-led Interventions

Background:

  • Antimicrobial stewardship initiatives are recommended for improving antimicrobial use in emergency departments.
  • A pharmacist-led antimicrobial stewardship (AMS) service was implemented in a pediatric emergency department (PED) to review microbiology results for discharged patients.

Purpose of the Study:

  • To evaluate the impact of a pharmacist-led AMS service compared to usual care in a PED.
  • To assess the effect on return visits, hospitalizations, and antimicrobial therapy appropriateness.

Main Methods:

  • Retrospective chart review of pediatric patients discharged from the PED.
  • Comparison of data from 6 months before and after the implementation of the pharmacist-led AMS service.
  • Analysis included return visits within 96 hours and 30-day outcomes, using chi-square tests and logistic regression.

Main Results:

  • No significant difference in return visits within 96 hours (12.0% vs. 10.0%) or 30-day return visits/hospitalization (22.1% vs. 19.9%).
  • A significant decrease in inappropriate antimicrobial therapy was observed post-implementation (7.0% vs. 5.0%, p=0.047).
  • Faster time to notification after discharge occurred more frequently in the post-implementation phase (53.3% vs. 40.3%, p=0.0298).

Conclusions:

  • The pharmacist-led AMS service did not significantly impact return visit or hospitalization rates.
  • The service may have contributed to more judicious antimicrobial use and improved timeliness of post-discharge notifications.
  • Further research could explore optimizing pharmacist roles in pediatric emergency care settings.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
181
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
160
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
222
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
864
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
253
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
209